• Aroa Biosurgery appointed Mark Dunwoodie chief financial officer and joint company secretary, effective November 16, 2026.
• Dunwoodie joins from NZX-listed Rakon Limited with more than 25 years of financial, strategic and operational leadership experience.
• Outgoing CFO James Agnew will depart on November 30 following half-year results and an investor roadshow, ending 13 years with the company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aroa Biosurgery Ltd. published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.